Eye injections of the drug Avastin, used to treat retinal diseases, bring no greater risk of endophthalmitis, a potentially blinding eye infection, than injections with the much more expensive drug ...
GlobalData on MSN
Outlook Therapeutics wins FDA approval for Lytenava in wet AMD
Outlook’s approval brings the first ophthalmic formulation of bevacizumab for the treatment of wet AMD.
MedPage Today on MSN
FDA approves branded bevacizumab for wet AMD
Approval follows 20 years of off-label use of compounded formulations of the VEGF inhibito ...
NEW YORK, Dec 19 (Reuters) - Genentech Inc notified doctors of 36 cases of eye inflammation among patients who received injections with the company's Avastin colon cancer drug for unapproved eye ...
Even without an FDA approval, Roche’s cancer drug Avastin is widely used by doctors to treat certain eye diseases. Outlook Therapeutics has been trying to get an official approval for a reformulated ...
Landmark FDA Approval Is an Important Milestone in Retina Care, Bringing Patients and Physicians an Ophthalmic Bevacizumab Developed Specifically ...
LONDON, June 11 (Reuters) - Roche's cancer drug Avastin is a cheap, effective treatment for preventing blindness and should be used routinely in countries that cannot afford the far more costly ...
Asianet Newsable on MSN
OTLK stock surges after FDA ends decade-long wait for ophthalmic bevacizumab
LYTENAVA is now the first and only FDA-approved version of the drug bevacizumab specifically made for injection into the eye ...
The FDA has issued an alert that repackaged intravitreal injections of the drug Avastin have caused at least a dozen serious eye infections in the Miami area, according to an FDA news release. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results